SCHEMBL7084067

SCHEMBL7084067

OC1(c2ccccc2F)CCC2(CC1)OCCO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.48
OPRD1 P41143 2/20 0.48
OPRK1 P41145 2/20 0.48
OPRL1 P41146 2/20 0.48
ALDH1A1 P00352 4/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
HDAC4 P56524 2/20 0.38
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GAA P10253 1/20 0.34
PDE10A Q9Y233 1/20 0.34
PDK2 Q15119 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23232242 0.85 OPRM1 (0.59) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL7081194 0.84 TXNRD1 (0.38) OPRM1OPRD1OPRK1ALDH1A1HPGD
SCHEMBL18021960 0.80 OPRM1 (0.51) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL20010827 0.79 OPRM1 (0.48) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL8357699 0.79 HDAC4 (0.36) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL20010316 0.79 HDAC4 (0.42) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL17982774 0.78 OPRL1 (0.53) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL17543131 0.78 ATM (0.39) ALDH1A1USP2POLBGAANPC1
SCHEMBL13674326 0.78 CYP17A1 (0.33) PDE10ANPC1RAB9A
SCHEMBL8359836 0.78 HDAC4 (0.48) OPRL1ALDH1A1HDAC4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998285-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-08 EP disclosed
US-6255315-B1 BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2001-07-03 US disclosed
EP-0998285-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-05-10 EP disclosed
US-6037354-A ADMINISTERING PHENYL-SUBSTITUTED THIAZOLIDIN-4-ONE OR OXAZOLIDIN-2-ONE DERIVATIVE TO TREAT BENIGN PROSTATE HYPERPLASIA; SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 2000-03-14 US disclosed
WO-1998057641-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed